Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 39 Records) |
Query Trace: DAXX[original query] |
---|
Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors. International journal of biological sciences 2016 12 (12): 1523-1532. Chou Wen-Chi, Lin Po-Han, Yeh Yi-Chen, Shyr Yi-Ming, Fang Wen-Liang, Wang Shin-E, Liu Chun-Yu, Chang Peter Mu-Hsin, Chen Ming-Han, Hung Yi-Ping, Li Chung-Pin, Chao Yee, Chen Ming-Hua |
In Japanese patients with papillary thyroid carcinoma, TERT promoter mutation is associated with poor prognosis, in contrast to BRAF mutation. Virchows Archiv : an international journal of pathology 2016 Oct . Nasirden Almira, Saito Tsuyoshi, Fukumura Yuki, Hara Kieko, Akaike Keisuke, Kurisaki-Arakawa Aiko, Asahina Miki, Yamashita Atsushi, Tomomasa Ran, Hayashi Takuo, Arakawa Atsushi, Yao Takas |
Clinicopathological analysis of ATRX, DAXX and NOTCH receptor expression in angiosarcomas. Histopathology 2017 Aug . Panse Gauri, Chrisinger John Sa, Leung Cheuk H, Ingram Davis R, Khan Samia, Wani Khalida, Lin Heather, Lazar Alexander J, Wang Wei-Li |
Serotonin, ATRX, and DAXX Expression in Pituitary Adenomas: Markers in the Differential Diagnosis of Neuroendocrine Tumors of the Sellar Region. The American journal of surgical pathology 2017 Jul . Casar-Borota Olivera, Botling Johan, Granberg Dan, Stigare Jerker, Wikström Johan, Boldt Henning Bünsow, Kristensen Bjarne Winther, Pontén Fredrik, Trouillas Jacqueli |
Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel. Oncotarget 2017 Nov 8 (55): 93464-93475. Gleeson Ferga C, Voss Jesse S, Kipp Benjamin R, Kerr Sarah E, Van Arnam John S, Mills John R, Marcou Cherisse A, Schneider Amber R, Tu Zheng Jin, Henry Michael R, Levy Michael |
ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors. Human pathology 2018 Aug . Chou Angela, Itchins Malinda, de Reuver Philip R, Arena Jennifer, Clarkson Adele, Sheen Amy, Sioson Loretta, Cheung Veronica, Perren Aurel, Nahm Christopher, Mittal Anubhav, Samra Jaswinder S, Pajic Marina, Gill Anthony |
Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma. Cancer cell 2018 Aug 34 (2): 242-255.e5. Gopal Raj K, Kübler Kirsten, Calvo Sarah E, Polak Paz, Livitz Dimitri, Rosebrock Daniel, Sadow Peter M, Campbell Braidie, Donovan Samuel E, Amin Salma, Gigliotti Benjamin J, Grabarek Zenon, Hess Julian M, Stewart Chip, Braunstein Lior Z, Arndt Peter F, Mordecai Scott, Shih Angela R, Chaves Frances, Zhan Tiannan, Lubitz Carrie C, Kim Jiwoong, Iafrate A John, Wirth Lori, Parangi Sareh, Leshchiner Ignaty, Daniels Gilbert H, Mootha Vamsi K, Dias-Santagata Dora, Getz Gad, McFadden David |
Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing. Journal of neuropathology and experimental neurology 2018 Aug 77 (8): 710-716. Cantero Diana, Rodríguez de Lope Ángel, Moreno de la Presa Raquel, Sepúlveda Juan M, Borrás José M, Castresana Javier S, D'Haene Nicky, García Juan F, Salmon Isabelle, Mollejo Manuela, Rey Juan A, Hernández-Laín Aurelio, Meléndez Bárba |
Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times. Gastroenterology 2018 2 154 (8): 2060-2063.e8. Roy Somak, LaFramboise William A, Liu Ta-Chiang, Cao Dengfeng, Luvison Alyssa, Miller Caitlyn, Lyons Maureen A, O'Sullivan Roderick J, Zureikat Amer H, Hogg Melissa E, Tsung Allan, Lee Kenneth K, Bahary Nathan, Brand Randall E, Chennat Jennifer S, Fasanella Kenneth E, McGrath Kevin, Nikiforova Marina N, Papachristou Georgios I, Slivka Adam, Zeh Herbert J, Singhi Aatur |
DAXX Mutation Status of Embolization-Treated Neuroendocrine Tumors Predicts Shorter Time to Hepatic Progression. Journal of vascular and interventional radiology : JVIR 2018 11 29 (11): 1519-1526. Ziv Etay, Rice Samuel L, Filtes John, Yarmohammadi Hooman, Boas F Edward, Erinjeri Joseph P, Petre Elena Nadia, Brody Lynn A, Brown Karen T, Covey Anne M, Getrajdman George I, Maybody Majid, Raj Nitya, Sofocleous Constantinos T, Solomon Stephen B, Reidy-Lagunes Dia |
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases. Annals of surgery 2018 10 271 (3): 566-573. Pea Antonio, Yu Jun, Marchionni Luigi, Noe Michael, Luchini Claudio, Pulvirenti Alessandra, de Wilde Roeland F, Brosens Lodewijk A, Rezaee Neda, Javed Ammar, Chianchiano Peter, Gobbo Stefano, Regi Paolo, Salvia Roberto, Bassi Claudio, He Jin, Weiss Matthew J, Cameron John L, Offerhaus G Johan A, Hruban Ralph H, Lawlor Rita T, Scarpa Aldo, Heaphy Christopher M, Wood Laura D, Wolfgang Christopher |
Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas. Oncotarget 2017 Dec 8 (65): 109228-109237. Juratli Tareq A, Thiede Christian, Koerner Mara V A, Tummala Shilpa S, Daubner Dirk, Shankar Ganesh M, Williams Erik A, Martinez-Lage Maria, Soucek Silke, Robel Katja, Penson Tristan, Krause Mechthild, Appold Steffen, Meinhardt Matthias, Pinzer Thomas, Miller Julie J, Krex Dietmar, Ely Heather A, Silverman Ian M, Christiansen Jason, Schackert Gabriele, Wakimoto Hiroaki, Kirsch Matthias, Brastianos Priscilla K, Cahill Daniel |
Discrimination of low- and high-grade appendiceal mucinous neoplasms by targeted sequencing of cancer-related variants. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2019 4 32 (8): 1197-1209. LaFramboise William A, Pai Reetesh K, Petrosko Patti, Belsky Michael A, Dhir Apoorv, Howard Peter G, Becich Michael J, Holtzman Matthew P, Ahrendt Steven A, Pingpank James F, Zeh Herbert J, Dhir Rajiv, Bartlett David L, Choudry Haroon |
Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors. Annals of surgery 2019 10 274 (6): e949-e956. Uemura Jun, Okano Keiichi, Oshima Minoru, Suto Hironobu, Ando Yasuhisa, Kumamoto Kensuke, Kadota Kyuichi, Ichihara Shuji, Kokudo Yasutaka, Maeba Takashi, Nanno Yoshihide, Toyama Hirochika, Takada Yasutsugu, Shimada Mitsuo, Hanazaki Kazuhiro, Masaki Tsutomu, Suzuki Yasuyu |
Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability. JCO precision oncology 2019 1 2018 . Raj Nitya, Shah Ronak, Stadler Zsofia, Mukherjee Semanti, Chou Joanne, Untch Brian, Li Janet, Kelly Virginia, Saltz Leonard B, Mandelker Diana, Ladanyi Marc, Berger Michael F, Klimstra David S, Reidy-Lagunes Diane, Osoba Muyin |
Genomic variation as a marker of response to neoadjuvant therapy in locally advanced rectal cancer. Molecular & cellular oncology 2020 7 (3): 1716618. Douglas Jason K, Callahan Rose E, Hothem Zachary A, Cousineau Craig S, Kawak Samer, Thibodeau Bryan J, Bergeron Shelli, Li Wei, Peeples Claire E, Wasvary Harry |
Alternative Lengthening of Telomeres Phenotype Predicts Progression Risk in Noninsulinomas in a Chinese Cohort. Neuroendocrinology 2021 8 112 (5): 510-522. Ban Xinchao, Mo Shengwei, Lu Zhaohui, Jia Congwei, Shao Huilin, Yan Jie, Chang Xiaoyan, Mao Xinxin, Wu Yan, Zhang Yue, Fan Xiaojie, Yu Shuangni, Chen J |
Prognostic Significance of Altered ATRX/DAXX Gene in Pancreatic Neuroendocrine Tumors: A Meta-Analysis. Frontiers in endocrinology 2021 12 691557. Wang Fei, Xu Xiaowu, Ye Zeng, Qin Yi, Yu Xianjun, Ji Shunro |
Coexistence of TERT C228T mutation and MALAT1 dysregulation in primary glioblastoma: new prognostic and therapeutic targets. Neurological research 2021 7 43 (11): 916-925. Ak Aksoy Secil, Mutlu Melis, Tunca Berrin, Kocaeli Hasan, Taskapilioglu Mevlut Ozgur, Bekar Ahmet, Tekin Cagla, Argadal Omer Gokay, Civan Muhammet Nafi, Kaya ?smail Seckin, Ocak P?nar Eser, Tolunay Sahsi |
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association. Communications biology 2021 2 4 (1): 155. Lakis Vanessa, Lawlor Rita T, Newell Felicity, Patch Ann-Marie, Mafficini Andrea, Sadanandam Anguraj, Koufariotis Lambros T, Johnston Rebecca L, Leonard Conrad, Wood Scott, Rusev Borislav, Corbo Vincenzo, Luchini Claudio, Cingarlini Sara, Landoni Luca, Salvia Roberto, Milella Michele, Chang David, Bailey Peter, Jamieson Nigel B, Duthie Fraser, Gingras Marie-Claude, Muzny Donna M, Wheeler David A, Gibbs Richard A, Milione Massimo, , , Pederzoli Paolo, Samra Jaswinder S, Gill Anthony J, Johns Amber L, Pearson John V, Biankin Andrew V, Grimmond Sean M, Waddell Nicola, Nones Katia, Scarpa Al |
The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocrine-related cancer 2021 Oct . Venizelos Andreas, Elvebakken Hege, Perren Aurel, Nikolaienko Oleksii, Deng Wei, Lothe Inger Marie B, Couvelard Anne, Hjortland Geir Olav, Sundlöv Anna, Svensson Johanna, Garresori Harrish, Kersten Christian, Hofsli Eva, Detlefsen Sönke, Krogh Merete, Sorbye Halfdan, Knappskog Sti |
Sex-Based Clinicopathologic and Survival Differences Among Patients with Pancreatic Neuroendocrine Tumors. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2022 8 26 (11): 2321-2329. Greenberg Jacques A, Ivanov Nikolay A, Egan Caitlin E, Lee Yeon Joo, Zarnegar Rasa, Fahey Thomas J, Finnerty Brendan M, Min Irene |
Identification of potential biomarkers and novel therapeutic targets through genomic analysis of small cell bladder carcinoma and associated clinical outcomes. Urologic oncology 2022 May . Burgess Earle F, Sanders J Alexa, Livasy Chad, Symanowski James, Gatalica Zoran, Steuerwald Nury M, Arguello David, Brouwer Cory R, Korn W Michael, Grigg Claud M, Zhu Jason, Matulay Justin T, Clark Peter E, Heath Elisabeth I, Raghavan Der |
Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders. Journal of the Formosan Medical Association = Taiwan yi zhi 2022 6 121 (12): 2538-2547. Lin Po-Han, Tseng Ling-Ming, Lee Yi-Hsuan, Chen Shou-Tung, Yeh Dah-Cherng, Dai Ming-Shen, Liu Liang-Chih, Wang Ming-Yang, Lo Chiao, Chang Stanley, Tan Kien Thiam, Chen Shu-Jen, Kuo Sung-Hsin, Huang Chiun-She |
Convergence between germline and somatic mutations in pancreatic neuroendocrine tumors. European journal of endocrinology 2022 5 187 (1): 85-90. Ling Chao, Hong Xiafei, Xu Mengyue, Wang Yutong, Ma Xiaosen, Cui Yunying, Jiang Rui, Cao Dingyan, Wu Huanwen, Tong Anli, Zhao Yupei, Wu Wenmi |
Genetic and epigenetic prognosticators of neuroendocrine tumours of the GI tract, liver, biliary tract and pancreas: A systematic review and meta-analysis. Histopathology 2023 8 . Claudia Mestre-Alagarda, Rajaventhan Srirajaskanthan, Yoh Zen, Mojisola Giwa, Mark Howard, Marc Lucas Oo |
Molecular typing and mutational characterization of rectal neuroendocrine neoplasms. Cancer medicine 2023 6 . Xiaoling Duan, Man Zhao, Xiaolei Yin, Lili Mi, Jianfei Shi, Ning Li, Xin Han, Guangjie Han, Jinfeng Wang, Jiaojiao Hou, Fei Y |
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET). Diagnostics (Basel, Switzerland) 2023 5 13 (9): . Giuseppe Lamberti, Natalie Prinzi, Alberto Bongiovanni, Mariangela Torniai, Elisa Andrini, Dario de Biase, Deborah Malvi, Mirta Mosca, Rossana Berardi, Toni Ibrahim, Sara Pusceddu, Davide Campa |
Bilateral and synchronous male breast cancer: a case report. International journal of clinical and experimental pathology 2023 12 16 (11): 352-356. Shaoqiang Zhou, Jiankui Wang, Ming Li, Yinju Yang, Hushan Zhang, Dedian Ch |
Clinical utility of plasma cell-free DNA in pancreatic neuroendocrine neoplasms. Endocrine-related cancer 2024 1 . Darren Cowzer, Ronak H Shah, Joanne F Chou, Ritika Kundra, Sippy Punn, Laura Fiedler, April DeMore, Marinela Capanu, Michael F Berger, Diane Reidy-Lagunes, Nitya R |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: